Financials NKMAX CO., Ltd.

Equities

A182400

KR7182400002

Biotechnology & Medical Research

End-of-day quote Korea S.E. 19:00:00 2024-03-24 EDT 5-day change 1st Jan Change
2,020 KRW +9.54% Intraday chart for NKMAX CO., Ltd. -.--% -67.58%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 321,353 337,280 712,301 842,433 544,996 516,267
Enterprise Value (EV) 1 309,494 379,655 741,191 861,281 588,273 567,785
P/E ratio -15.6 x -26.8 x -16.5 x -15.8 x -10.1 x 104 x
Yield - - - - - -
Capitalization / Revenue 51.3 x 38.5 x 68.7 x 64.7 x 48.4 x 47.9 x
EV / Revenue 49.4 x 43.4 x 71.5 x 66.1 x 52.2 x 52.7 x
EV / EBITDA -22.9 x -19.4 x -21.9 x -22.1 x -14.7 x -10.9 x
EV / FCF -15.6 x -16.4 x -39.5 x -52 x -42.3 x -21.4 x
FCF Yield -6.41% -6.1% -2.53% -1.92% -2.36% -4.67%
Price to Book 9.21 x 3.14 x 6.01 x 7.12 x 6.37 x 4.61 x
Nbr of stocks (in thousands) 49,630 62,459 67,838 75,050 79,562 82,868
Reference price 2 6,475 5,400 10,500 11,225 6,850 6,230
Announcement Date 3/18/19 3/19/20 3/19/21 3/21/22 3/20/23 4/5/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 6,269 8,749 10,372 13,020 11,263 10,769
EBITDA 1 -13,503 -19,545 -33,851 -38,988 -40,149 -52,328
EBIT 1 -14,434 -24,496 -41,197 -47,440 -49,653 -60,829
Operating Margin -230.24% -279.98% -397.21% -364.36% -440.86% -564.84%
Earnings before Tax (EBT) 1 -22,409 -11,343 -43,138 -50,095 -56,658 -37,485
Net income 1 -20,453 -11,429 -41,439 -50,336 -53,505 5,261
Net margin -326.27% -130.63% -399.54% -386.6% -475.06% 48.85%
EPS 2 -415.2 -201.5 -636.1 -709.8 -679.4 60.00
Free Cash Flow 1 -19,826 -23,163 -18,775 -16,554 -13,904 -26,494
FCF margin -316.26% -264.74% -181.02% -127.14% -123.46% -246.01%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/18/19 3/19/20 3/19/21 3/21/22 3/20/23 4/5/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 42,375 28,889 18,848 43,276 51,518
Net Cash position 1 11,859 - - - - -
Leverage (Debt/EBITDA) - -2.168 x -0.8534 x -0.4834 x -1.078 x -0.9845 x
Free Cash Flow 1 -19,826 -23,163 -18,775 -16,554 -13,904 -26,494
ROE (net income / shareholders' equity) -54.7% -16.1% -36.4% -42.6% -54.8% -37.1%
ROA (Net income/ Total Assets) -14.5% -12.1% -13.3% -15.4% -17.7% -21.5%
Assets 1 141,261 94,332 311,794 327,572 301,976 -24,500
Book Value Per Share 2 703.0 1,721 1,748 1,576 1,076 1,353
Cash Flow per Share 2 16.70 204.0 226.0 155.0 74.10 7.960
Capex 1 638 11,723 857 1,379 926 590
Capex / Sales 10.17% 133.99% 8.27% 10.59% 8.22% 5.48%
Announcement Date 3/18/19 3/19/20 3/19/21 3/21/22 3/20/23 4/5/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A182400 Stock
  4. Financials NKMAX CO., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW